IDEAYA Biosciences IDYA 深 滬
已收盤 10-24 16:00:00 美东时间
29.18
+0.760
+2.67%
華盛通- 最 高29.515
- 今 開28.69
- 成交量 86.42万股
- 最 低 28.38
- 昨 收 28.42
- 總市值 25.57亿
- 52周最高 32.67
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 13.45
- 委 比 70.94%
- 總股本 8764.37万
- 歷史最高 47.735
- 量 比 0.49
- 振 幅 3.99%
- 歷史最低 2.95
- 每 手 1
- 風險率 3.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 上调目标价！特斯拉、赛默飞世尔、拉姆研究、波士顿科学、安诺电子、金沙集团等获众多机构评级
今日重点评级关注：摩根士丹利：维持Viking Therapeutics"超配"评级，目标价从98美元升至102美元；摩根大通：维持IDEAYA Biosciences"超配"评级，目标价从74美元升至79美元
10-24 09:51
美股大行评级 | 富国银行上调苹果目标价升至290美元；"卖出"！花旗下调NuScale Power、阿特斯太阳能评级
今日重点评级关注：摩根大通：维持Cogent Biosciences"超配"评级，目标价从30美元升至44美元；Piper Sandler：维持Vital Energy"中性"评级，目标价从16美元升至30美元
10-22 10:10
BTIG Reiterates Buy on IDEAYA Biosciences, Maintains $62 Price Target
BTIG analyst Justin Zelin reiterates IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and maintains $62 price target.
10-21 18:11
Ideaya Biosciences Reports Median Overall Survival Results From Phase 1/2 Trial (OptimUM-01) Of Darovasertib In Combination With Pfizer's Crizotinib1X For Metastatic Uveal Melanoma
Combination demonstrated median overall survival (OS) of 21.1 months, compared to reported historical mOS of approximately 12 months in published meta-analysis of metastatic uveal melanoma in the first-line settingMedian
10-20 18:12
Next-Generation Targeted Therapies Reshape Precision Oncology Landscape
USA News Group News Commentary – Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 15, 2025 /PRNewswire/ -- USA News Group News Commentary – Biomarker-driven drug development is acc...
10-15 21:11
Geron's COO Andrew Grethlein To Depart On October 15, 2025
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several
10-14 04:42
FIS Stock Outlook: Why Trouble May Linger Until 2028
Adhishthana.com Analysis reveals FIS stock remains troubled after a Cakra breakdown, with weak Triads suggesting no recovery before 2028.
10-01 18:02
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targe...
09-26 18:00
百奥赛图“双业务线”再提速：国际合作频现，布局核酸递送与双抗ADC新赛道
2025年9月，创新药研发平台型企业百奥赛图在过去一个月连续发布多项重要合作进展。无论是与跨国巨头默克在抗体偶联脂质纳米颗粒（LNP）递送方案上的探索，还是...
09-23 10:10
百奥赛图“双业务线”持续放量：多项国际合作开启新阶段
近期，百奥赛图在全球创新药产业链上的存在感愈发强烈。进入9月，公司接连发布三项合作消息，涵盖核酸药物递送、ADC研发与双抗ADC合作项目进展，充分展现了其...
09-22 14:07
